By Fiona Macrae
A prostate cancer ‘wonder pill’ could be on the market next year.
Abiraterone hit the headlines two years ago, with stunning trial results in which it shrank tumours in 80 per cent of men whose cancer had spread throughout their body.
The once-a-day drug also eased pain in many and was hailed as the biggest breakthrough in the field for 60 years. Read More…
